Skip to main content

Animations

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Test tubes in a research lab.

    Exenatide, a GLP-1 Drug, Shows No Impact on Parkinson’s Symptoms

    In a clinical trial, exenatide, a GLP-1 receptor agonist, showed no impact on slowing the progression of Parkinson’s disease or improving symptoms.
    Learn more

  • Patient speaks with doctor in an office

    Second Under-the-Skin Infusion for Parkinson’s Earns FDA Approval

    The U.S. Food and Drug Administration has approved Onapgo, a continuous, under-the-skin infusion of apomorphine for the treatment of Parkinson’s motor symptoms.
    Learn more

  • Test tubes in a research lab.

    News in Context: Mixed Results from Two Experimental Drugs Targeting Alpha-Synuclein

    This week, pharmaceutical companies reported results from two Phase II clinical trials of two respective experimental drugs designed to slow the progression of PD by targeting alpha-synuclein.
    Learn more

  • Allie Vaiana, PhD

    Allie Vaiana, PhD, Searches for Better Ways to Target Parkinson’s Symptoms

    Allie Vaiana, PhD, is a senior scientific portfolio manager on MJFF’s translational research team. In our researcher spotlight series, we learn more about Allie’s work.
    Learn more

  • PET images

    Closing In on a Groundbreaking Imaging Tool for Parkinson's Disease

    This year, Parkinson's researchers are hopeful for another breakthrough biomarker: an imaging tool that would allow them to see the alpha-synuclein clumping proteins inside the brains of people…
    Learn more

  • Brain Scan on Tablet

    What We Fund: $100.4M toward Novel Approaches to Reduce Freezing of Gait and Improve Understanding of Parkinson’s Environment Risk Factors

    In October and November, 2024, The Michael J. Fox Foundation for Parkinson’s Research announced 79 grants totaling more than $100.4 million.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.